Stuttgart - Delayed Quote EUR

Apellis Pharmaceuticals Inc (1JK.SG)

15.31
-0.11
(-0.69%)
As of 8:05:16 AM GMT+2. Market Open.
Loading Chart for 1JK.SG
  • Previous Close 15.41
  • Open 15.31
  • Bid 15.03 x --
  • Ask 15.11 x --
  • Day's Range 15.31 - 15.31
  • 52 Week Range 15.17 - 39.92
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 1JK.SG

View More

Performance Overview: 1JK.SG

Trailing total returns as of 5/14/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

1JK.SG
50.67%
S&P 500 (^GSPC)
0.15%

1-Year Return

1JK.SG
59.80%
S&P 500 (^GSPC)
12.27%

3-Year Return

1JK.SG
70.43%
S&P 500 (^GSPC)
46.38%

5-Year Return

1JK.SG
70.43%
S&P 500 (^GSPC)
106.50%

Compare To: 1JK.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1JK.SG

View More

Valuation Measures

As of 5/13/2025
  • Market Cap

    1.96B

  • Enterprise Value

    2.06B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.74

  • Price/Book (mrq)

    13.09

  • Enterprise Value/Revenue

    2.94

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1JK.SG

View More